Steven Cohen's position in Sangamo Therapeutics is currently worth $1.59 Million. That's 0.00% of their equity portfolio (711th largest holding). The first Sangamo Therapeutics trade was made in Q2 2014. Since then Steven Cohen bought shares eight more times and sold shares on nine occasions. The investor's estimated purchase price is $4.17 Million, resulting in a loss of 62%.